Stock Markets March 31, 2026

Meta Expands Ray-Ban Prescription Smart-Glass Line with Two New Models

New offerings broaden prescription options as Meta continues large-scale investments in AI-enabled personal devices

By Hana Yamamoto META
Meta Expands Ray-Ban Prescription Smart-Glass Line with Two New Models
META

On March 31, Meta Platforms added two new prescription versions to its Ray-Ban smart-glass lineup, widening choices for vision-correcting consumers. The launch underscores Meta's continued push into AI hardware — developed in partnership with Ray-Ban owner EssilorLuxottica — as the company pursues its vision of 'personal superintelligence' and allocates substantial capital toward that goal.

Key Points

  • Meta launched two new Ray-Ban prescription smart-glass models on March 31, expanding choices for consumers who require corrective lenses.
  • The smart-glass development is a partnership between Meta and EssilorLuxottica, the owner of the Ray-Ban brand, and the category is described as one of the few breakthrough successes in AI-driven consumer gadgets.
  • Meta has been directing hundreds of billions of dollars toward its strategy of 'personal superintelligence,' aiming to bring AI capabilities to individual users via advanced devices.

March 31 - Meta Platforms introduced two additional Ray-Ban prescription smart-glass models on Tuesday, increasing the number of prescription eyewear options available from the company. The move comes as the social media and technology company continues to push into AI-enabled consumer hardware.

Meta has framed the expansion as responsive to the large potential user base for prescription devices. CEO Mark Zuckerberg noted in January that "billions of people wear glasses or contacts for vision correction," a remark the company has used to highlight the market opportunity for its smart-glass products.

The company develops these AI-equipped glasses in collaboration with EssilorLuxottica, the owner of the Ray-Ban brand. Meta describes the product category as one of the relatively few successes so far among AI-driven consumer gadgets, and the new launches are positioned to broaden the selection for customers who require corrective lenses.

Meta has committed substantial financial resources to the broader effort. The company has been investing hundreds of billions of dollars toward what it calls "personal superintelligence," a strategic priority in which advanced devices and related technologies are intended to deliver AI-powered functionality directly to individuals.

Separately, a product evaluation service called ProPicks AI assesses META along with thousands of other companies each month using more than 100 financial metrics. The service emphasizes data-driven, quantitative screening to identify companies it considers attractive from a risk-reward perspective, and it cites past examples of notable performers it highlights in its coverage.

The two new prescription Ray-Ban smart-glass models extend Meta's product range without additional public detail in this announcement on pricing, availability, or technical specifications. The company and its partner EssilorLuxottica remain the named developers of the devices.


Bottom line: Meta has expanded its Ray-Ban prescription smart-glass lineup with two new models, reinforcing its investment in AI-enabled personal devices and its collaboration with EssilorLuxottica.

Risks

  • The article does not provide details on pricing, availability or technical specifications for the new prescription models, leaving commercial terms and consumer uptake unclear - impacting consumer electronics and retail sectors.
  • Meta's investments are described as amounting to hundreds of billions of dollars, but the piece does not supply information on expected returns or timelines for those expenditures - a financial consideration for the technology sector and investors.

More from Stock Markets

Constellation Energy Shares Drop After 2026 EPS Guidance Comes in Below Street Estimates Mar 31, 2026 Middle East conflict upends refrigerated drug routes, threatens cancer treatment supply chains Mar 31, 2026 Market Movers Tuesday: Nvidia, Meta Lead Gains as Select Energy and Healthcare Names Slide Mar 31, 2026 Major Carriers Extend Cancellations as Middle East Airspace Disruptions Persist Mar 31, 2026 CloudSEK CEO: Iran Conflict Highlights Central Role of Cyber Operations in Contemporary Warfare Mar 31, 2026